Analyst consensus rating
Achieve Life Sciences Analyst Rating: Strong Buy
ACHV is rated Strong Buy by 12 analysts with a $13.83 target. As of 2026-08-28.
Direct answer
Achieve Life Sciences's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.83.
Forecast evidence checked August 28, 2026.
Get free Achieve Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.08
- Average price target
- $13.83
- High price target
- $21.00
- Low price target
- $9.00
- Low target gap
- +11.5%
- Target upside
- +71.3%
- High target gap
- +160.1%
- Target range width
- 148.6%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Achieve Life Sciences?
Achieve Life Sciences has a verified Strong Buy consensus. The same dataset has an average price target of $13.83.
How far are Achieve Life Sciences's low and high targets from the recorded price?
The low target implies +11.5%, while the high target implies +160.1%.
How many analysts are included in Achieve Life Sciences's consensus?
The verified consensus includes 12 analysts.
How is Achieve Life Sciences's target upside or downside calculated?
The average target of $13.83 is divided by the recorded price of $8.08, then one is subtracted to produce +71.3%. This does not guarantee a future return.
When was Achieve Life Sciences's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.